In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Precigen Inc (NASDAQ: PGEN) closed at $1.24 in the last session, down -7.46% from day before closing price of $1.34. In other words, the price has decreased by -$7.46 from its previous closing price. On the day, 2.31 million shares were traded. PGEN stock price reached its highest trading level at $1.33 during the session, while it also had its lowest trading level at $1.21.
Ratios:
We take a closer look at PGEN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.76 and its Current Ratio is at 4.76. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 18, 2022, with a $7 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 09 ’24 when Perez Jeffrey Thomas bought 58,823 shares for $0.85 per share. The transaction valued at 50,000 led to the insider holds 743,097 shares of the business.
KIRK RANDAL J bought 23,529,411 shares of PGEN for $19,999,999 on Aug 09 ’24. The Director now owns 64,547,214 shares after completing the transaction at $0.85 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 364613344 and an Enterprise Value of 300423296. For the stock, the TTM Price-to-Sale (P/S) ratio is 93.01 while its Price-to-Book (P/B) ratio in mrq is 9.43. Its current Enterprise Value per Revenue stands at 76.541 whereas that against EBITDA is -3.331.
Stock Price History:
The Beta on a monthly basis for PGEN is 1.84, which has changed by -0.12056738 over the last 52 weeks, in comparison to a change of -0.024663687 over the same period for the S&P500. Over the past 52 weeks, PGEN has reached a high of $2.17, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is -25.81%, while the 200-Day Moving Average is calculated to be 0.08%.
Shares Statistics:
According to the various share statistics, PGEN traded on average about 1.81M shares per day over the past 3-months and 1393950 shares per day over the past 10 days. A total of 292.87M shares are outstanding, with a floating share count of 162.39M. Insiders hold about 44.77% of the company’s shares, while institutions hold 25.86% stake in the company. Shares short for PGEN as of 1741910400 were 22657367 with a Short Ratio of 12.51, compared to 1739491200 on 19049259. Therefore, it implies a Short% of Shares Outstanding of 22657367 and a Short% of Float of 11.73.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.19 and -$0.29 for the fiscal current year, implying an average EPS of -$0.24. EPS for the following year is -$0.01, with 1.0 analysts recommending between -$0.01 and -$0.01.
Revenue Estimates
Based on 2 analysts’ estimates, the company’s revenue will be $132.73M in the next fiscal year. The high estimate is $172.4M and the low estimate is $93.06M.
